View in EDS HTML Full Text PDF Full Text

Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide.

Saved in:
Bibliographic Details
Title: Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide.
Authors: Wang Q; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Department of Dermatology, Changxing People's Hospital, Huzhou, China., Ren ZT; The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Wu HF; Department of Urology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Gu HC; The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Li XW; Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Tang ZL; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Source: Frontiers in immunology [Front Immunol] 2025 Feb 20; Vol. 16, pp. 1530919. Date of Electronic Publication: 2025 Feb 20 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40051628
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Department of Dermatology, Changxing People's Hospital, Huzhou, China.<br /><searchLink fieldCode="AU" term="%22Ren+ZT%22">Ren ZT</searchLink>; The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Wu+HF%22">Wu HF</searchLink>; Department of Urology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Gu+HC%22">Gu HC</searchLink>; The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+XW%22">Li XW</searchLink>; Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Tang+ZL%22">Tang ZL</searchLink>; Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Feb 20; Vol. 16, pp. 1530919. <i>Date of Electronic Publication: </i>2025 Feb 20 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40051628
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1530919
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1530919
    Titles:
      – TitleFull: Dermatological adverse events in Chinese prostate cancer patients treated with the androgen receptor inhibitor apalutamide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang Q
      – PersonEntity:
          Name:
            NameFull: Ren ZT
      – PersonEntity:
          Name:
            NameFull: Wu HF
      – PersonEntity:
          Name:
            NameFull: Gu HC
      – PersonEntity:
          Name:
            NameFull: Li XW
      – PersonEntity:
          Name:
            NameFull: Tang ZL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 02
              Text: 2025 Feb 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1